首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1345379

全球组织处理系统市场 - 2023-2030

Global Tissue Processing Systems Market - 2023-2030

出版日期: 2023年09月06日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球组织处理系统市场在 2022 年达到 3.832 亿美元，预计到 2030 年将达到 5.786 亿美元，2023-2030 年预测期间复合年增长率为 5.4%。全球组织加工系统市场受到多种因素的推动，例如人口老龄化的增加、生活方式疾病的增加、技术的进步以及政府不断采取的措施，以提供方便和高质量的医疗保健选择。

组织处理涉及将固定的动物或人体组织转移到切片机中进行组织学蜡植入和切片切割。它涉及去除细胞中的水并用冷冻培养基代替以製成薄片。经过适当的修復后，组织会经历脱水、清洁和渗透。

组织学实验室的组织处理包括准备用于疾病诊断的身体组织，以及製作供病理学家在显微镜下观察的显微载玻片，技术包括活检、手术标本和尸检组织。组织技术专家处理组织处理和玻璃显微镜载玻片。

市场动态

癌症患病率上升

癌症患病率的上升是预测期内帮助市场增长的关键因素之一。组织处理系统广泛应用于癌症诊断实验室。活检样本在组织处理器中进行处理以进行癌症诊断。他们可以管理大量样品、快速处理样品并产生高质量的结果。

这些系统在製备和处理用于病理检查、诊断和研究的组织样本方面发挥着至关重要的作用。随着对准确、高效的癌症诊断和治疗的需求不断增长，组织处理系统成为实验室和医疗机构的重要工具。

例如，根据美国癌症协会的数据，预计 2023 年美国将新增 1,958,310 例癌症病例，约 609,820 人死于癌症，即每天约 1,670 人死亡。癌症是美国第二大常见死因，仅次于心脏病。

技术进步的崛起

近年来，组织处理程序得到了显着改进。组织处理机自动化具有多种优势，包括改善流体循环、节省时间和温度控制。自动化组织处理机的其他优点包括大大增强的组织处理、自动清洁循环和试剂管理系统。此外，它有助于减少人为错误。这提高了技术先进的组织加工机的可接受性，从而增加了对组织加工设备的需求。

缺乏训练有素的专业人员

组织处理系统市场训练有素的专业人员短缺是由于专业技能、教育计划以及对医学研究、诊断和生物技术专家不断增长的需求等因素造成的。组织处理机、切片机和染色机等设备的复杂性进一步限制了熟练从业人员的数量。

为了解决这个问题，需要学术界、工业界和专业组织之间的合作，包括专业教育、专业发展投资、公众意识、研究合作以及学徒和实习计划。

有关此报告的更多详细信息 - 索取样品

Market Overview

Global Tissue Processing Systems Market reached US$ 383.2 million in 2022 and is expected to reach US$ 578.6 million by 2030 growing with a CAGR of 5.4% during the forecast period 2023-2030. The global tissue processing systems market is driven by various factors like an increase in the ageing population, an rise in lifestyle diseases, technological advancements, and rising government initiatives to provide accessible and high-quality healthcare options.

Tissue processing involves transferring fixed animal or human tissue to a microtome for histological wax implantation and section cutting. It involves removing water from cells and replacing it with frozen media for thin slices. After proper repair, the tissue undergoes dehydration, cleansing and infiltration.

Tissue processing in the histology laboratory involves preparing body tissues for disease diagnosis and producing microscopic slides for pathologists to view under a microscope and techniques include biopsies, surgical specimens, and autopsy tissues. Histotechnologists handle tissue processing and glass microscopic slides.

Market Dynamics

Rise in the Prevalence of Cancer Diseases

The rise in the prevalence of cancer is one of the key factors that helps the market to grow during the forecast period. Tissue processing systems are widely used in cancer diagnostic laboratories. Biopsy samples are processed in tissue processors for cancer diagnosis. They can manage a large number of samples, quickly process the samples, and produce high-quality results.

These systems play a crucial role in preparing and processing tissue samples for pathological examination, diagnosis, and research. As the need for accurate and efficient cancer diagnosis and treatment grows, tissue processor systems become essential tools for laboratories and healthcare facilities.

For instance, according to American Cancer Society data, in 2023 there are projected to be 1,958,310 new cancer cases and approximately 609,820 deaths from cancer are expected in the US in 2023 which is about 1,670 deaths per day. Cancer is the second most common cause of death in the US, exceeded only by heart disease.

Rise in Technological Advancements

Tissue processing procedures have been considerably improved in recent years. Tissue processor automation has several advantages, including improved fluid circulation, time savings, and temperature control. Other advantages of automated tissue processors include greatly enhanced tissue processing, automatic cleaning cycles, and reagent management systems. Furthermore, it aids in the reduction of human mistakes. This raises the acceptability of technologically sophisticated tissue processors, hence increasing demand for tissue processing equipment.

Lack of Trained Professionals

The shortage of trained professionals in the tissue processing systems market is due to factors like specialized skill sets, educational programs, and the growing demand for experts in medical research, diagnostics, and biotechnology. The intricate nature of equipment, such as tissue processors, microtomes, and staining machines, further limits the pool of skilled practitioners.

To address this issue, collaboration between academia, industry, and professional organizations is needed, including specialized education, investment in professional development, public awareness, research collaborations, and apprenticeship and internship initiatives.

For more details on this report - Request for Sample

Segment Analysis

The global tissue processing systems market is segmented based on product type, modality, technology, end user and region.

The Small Volume Tissue Processors From The Product Segment Accounted for Approximately 42.1 % of the Tissue Processing Systems Market Share

The small volume of tissue processors from the product segment with around 42.1% is expected to dominate during the forecast period. These are suitable for small laboratory sizes as well as also save space the factors supporting its demand and growth in the market. For instance, the Leica TP1020 semi-enclosed rotary processor is designed for reliability and economy. It can optimize laboratory space with the small footprint of the HistoCore PEARL tissue processor. It is a semi-enclosed benchtop tissue processor with small volumes (≤200 blocks/day).

Geographical Penetration

North America Accounted for Approximately 37.9% of the Market Share in 2022

North America is estimated to hold about 37.9% of the total market share throughout the forecast period, due to the launches of new tissue processors, technological advancements, expansion by key players, growing geriatric population along with adoption of innovative medical technology, rise in cancer incidence, and raising awareness about cancer screening in this region.

For instance, on 3rd February 2022, Leica Biosystems expanded its Dual-Retort Tissue Processor portfolio in North America with HistoCore PEGASUS. The main issue with tissue processing is processing biopsy and large routine specimens in the same run, causing under- or over-processing. In ideal scenarios, biopsy and larger sample tissues should be processed separately using a specific protocol.

Competitive Landscape

The major global players in the tissue processing systems market include JOKOH, Danaher(Leica Biosystems Nussloch GmbH), Medite Medical GmbH, Milestone SRL, Sakura Finetek USA, Inc., SLEE medical GmbH, Bio Optica, Histo-Line Laboratories, General Data Company Inc, Unimeditrek and among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the histology equipment industry, limiting demand for slide staining and tissue processing systems. Clinical testing providers face logistical challenges such as transportation of tissue samples, access to microscopes, and IT systems. However, companies like Roche Digital Pathology have made decisive steps to overcome these challenges, offering a comprehensive solution for chronic illness diagnosis. This will likely significantly influence the worldwide tissue processing systems market.

Russia Ukraine Conflict Analysis

The Russia-Ukraine war significantly impacted the tissue processing systems market, causing supply chain disruptions and increased raw material costs. Sanctions from several countries cut supply while rising inflation presents new challenges for manufacturers.

By Product Type

Small-volume tissue processors
Medium Volume tissue processors
High Volume tissue processors

By Modality

Bench Top tissue processing unit
Portable tissue processing unit

By Technology

Microwave tissue processors
Vaccum tissue processors

By End User

Hospitals
Academic and Research Institutes
Diagnostic Laboratories
Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In March 2023, Virscio, a leading provider of translational research and development services, launched a new Pathology and Tissue Pharmacodynamics Division to enhance preclinical drug development programs. The division, led by Dr Jennifer Cann and Richard Bouffard, offers comprehensive non-GLP, GLP, and GCLP histology and pathology services, including tissue processing, slide preparation, staining, immunohistochemistry, digital slide scanning, quantitative image analysis, and pathology interpretation.
In September 2022, the histopathology company Sakura Finetek Europe announced the launch of its newest solution Tissue-Tek Genie, an advanced staining system, entering the market.
In September 2020, Sakura Finetek USA, Inc. announced the launch of two new laser-printable tissue cassettes, broadening the Tissue-Tek Paraform Sectionable Cassette System for use on the Tissue-Tek AutoTEC a120 Automated Embedding Systems.

Why Purchase the Report?

To visualize the global tissue processing systems market segmentation based on product type, modality, technology, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of tissue processing systems market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global tissue processing systems market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Modality
3.3. Snippet by Technology
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Prevalence of Cancer Diseases
  - 4.1.1.2. Rise in Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Trained Professionals
- 4.1.3. Opportunity
  - 4.1.3.1. Rise in Focus on Personalized Medicine
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post Covid-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Small Volume Tissue Processors *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Medium Volume Tissue Processors
7.4. High Volume Tissue Processors

8. By Modality

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 8.1.2. Market Attractiveness Index, By Modality
8.2. Bench Top Tissue Processing Unit*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Portable Tissue Processing Unit

9. By Technology

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.1.2. Market Attractiveness Index, By Technology
9.2. Microwave Tissue Processors *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Vaccum Tissue Processors

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Academic and Research Institutes
10.4. Diagnostic Laboratories
10.5. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Spain
  - 11.3.7.5. Italy
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan

Australia

11.5.7.4. Rest of Asia-Pacific

11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Danaher(Leica Biosystems Nussloch GmbH)*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. JOKOH
13.3. Medite Medical GmbH
13.4. Milestone SRL
13.5. Sakura Finetek USA, Inc.
13.6. SLEE medical GmbH
13.7. Bio Optica
13.8. Histo-Line Laboratories
13.9. General Data Company Inc
13.10. Unimeditrek

LIST NOT EXHAUSTIVE

14. Appendix

14.1. About Us and Services
14.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球组织处理系统市场 - 2023-2030

Global Tissue Processing Systems Market - 2023-2030

市场概况

市场动态

目录

第 1 章：方法和范围

第 2 章：定义和概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：行业分析

第 6 章：COVID-19 分析

第 7 章：副产品

第 8 章：按形态

第 9 章：按技术

第 10 章：最终用户

第 11 章：按地区

第 12 章：竞争格局

第 13 章：公司简介

第 14 章：附录